# Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer

> **NCT06295588** · PHASE2 · RECRUITING · sponsor: **University of Rochester** · enrollment: 40 (estimated)

## Conditions studied

- Fatigue
- Inflammation

## Interventions

- **DRUG:** Fucoidan extracted from F. Vesiculosus
- **DRUG:** Fucoidan extracted from U. Pinnatifida

## Key facts

- **NCT ID:** NCT06295588
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-26
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06295588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06295588, "Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06295588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*